Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
View Patent ↗The present invention relates to the use of tetrahydrocannabivarin (THCV) in the treatment of nausea and vomiting. Preferably the THCV is isolated and/or purified from cannabis plant extracts. Preferably the nausea and/or vomiting is caused by the effects of a medication such as a chemotherapeutic agent.
1. A method for treating nausea and/or vomiting comprising administering to a subject in need thereof a therapeutically effective amount of a phytocannabinoid tetrahydrocannabivarin (THCV), wherein cannabidiol (CBD) and cannabidivarin (CBDV) are not administered to the subject.
2. The method of claim 1 , wherein the nausea and/or vomiting is caused by the effects of a medication.
3. The method of claim 2 , wherein the medication is a chemotherapeutic medicine.
4. The method of claim 1 , wherein the THCV is present in an effective human daily dose to reduce or relieve nausea and/or vomiting.
5. The method of claim 4 , wherein the effective human daily dose of THCV is between 1 mg and 2000 mg.
6. The method of claim 5 , wherein the effective human daily dose of THCV is between 10 mg and 1000 mg.
7. The method of claim 1 , wherein the THCV is packaged for use for an extended treatment period.
8. The method of claim 7 , wherein the extended treatment period is at least 7 days.
9. The method of claim 1 further comprising administering the THCV in combination with one or more other medicinal substances.
10. The method of claim 1 , wherein the THCV is in an isolated or substantially pure form.
11. The method of claim 1 , wherein the THCV is in the form of a botanical drug substance.
12. The method of claim 11 , wherein all or a substantial proportion of tetrahydrocannabinol (THC) has been removed.